Annual report pursuant to Section 13 and 15(d)

Income Taxes

v3.20.2
Income Taxes
12 Months Ended
Jul. 31, 2020
Income Tax Disclosure [Abstract]  
Income Taxes

Note 9—Income Taxes

 

The FASB Topic on Income Taxes prescribes a recognition threshold and measurement attribute criteria for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. The Company has had no unrecognized tax benefits.

 

The Company recognizes interest and/or penalties related to income tax matters in income tax expense. The Company has not recognized any interest and/or penalties in the accompanying consolidated statements of operations for the year ended July 31, 2020 and 2019.

 

The Company is subject to taxation in the United States, various states and in Australia. The Company’s tax years for 2007 and forward, 2010 and forward and 2017 and forward are subject to examination by the United States federal tax authorities, California tax authorities and New Jersey tax authorities, respectively, due to the carry forward of unutilized net operating losses and research and development credits.

 

At July 31, 2020, the Company had federal, New Jersey and California net operating loss carryforwards of approximately $170 million, $67 million and $87 million, respectively. In addition, the Company has federal, California and New Jersey research and development tax credit carryforwards of approximately $2.4 million, $2.0 million and $0.3 million, respectively. The Company also has California Hiring Credits of approximately $9,300. The federal net operating losses incurred in years beginning after January 1, 2018 in the amount of $67 million can be carried forward indefinitely. The remaining $103 million of federal net operating loss, research tax credit carryforwards and New Jersey and California net operating loss carryforwards will begin to expire in 2029 unless previously utilized. The California research and development credit carryforwards will carry forward indefinitely until utilized. The Company has foreign net operating loss carryforwards in Australia of $1.0 million.

 

The Company has not completed a study to assess whether one or more ownership changes, as defined by IRC Section 382/383 of the Internal Revenue Code of 1986, as amended (the “Code”), have occurred since the Company’s formation, due to the complexity and cost associated with such a study, and the fact that there may be additional such ownership changes in the future. Based on a preliminary assessment, the Company believes that ownership changes have occurred. The Company estimates that if such an ownership change had occurred, the federal and state net operating loss carry-forwards and research and development tax credits that can be utilized in the future will be significantly limited. The Company may never be able to realize the benefit of some or all of the federal and state net loss carryforwards or research and development tax credit carryforwards, either due to ongoing operating losses or due to ownership changes, which limits the usefulness of the loss carryforwards.

 

Set forth below is the (benefit) provision for income taxes for continuing operations for the years ended July,31:

 

    2020     2019  
Current:   $       $    
Federal     -       -  
State     (872,000 )     1,300  
Foreign     -       -  
Total (benefit from) provision for income taxes   $ (872,000 )   $ 1,300  

 

Significant components of the Company’s deferred tax assets as of July 31, 2020 and 2019 are listed below:

 

    2020     2019  
Net operating loss carryforwards   $ 46,623,000     $ 35,361,000  
Credits     4,311,000       3,257,000  
Start-up costs     21,000       23,000  
Accumulated depreciation     98,000       122,000  
Option and stock awards     386,000       4,825,000  
Other     122,000       241,000  
Net deferred tax assets     51,561,000       43,829,000  
Valuation allowance for deferred tax assets     (51,561,000 )     (43,829,000 )
Net deferred taxes   $ -       -  

 

A valuation allowance of $51.6 million and $43.8 million at July 31, 2020 and 2019, respectively, has been recognized to offset the net deferred tax assets as realization of such assets is uncertain. The valuation allowance increased by $7.8 million and increased by $6.6 million for the years ended July 31, 2020 and 2019, respectively.

 

A reconciliation of income taxes using the statutory income tax rate, compared to the effective rate, is as follows:

 

    2020     2019  
Federal tax benefit at the expected statutory rate     21.00 %     21.00 %
State income tax, net of federal tax benefit     1.60 %     (0.01 )%
Non-deductible expenses     (0.76 )%     (0.46 )%
Tax impact of stock option cancellations     (10.04 )%     - %
Change in valuation allowance     (11.46 )%     (21.32 )%
Other     1.68 %     0.79 %
Income tax benefit - effective rate     2.02 %     (0.00 )%

 

Sale of New Jersey Net Operating Losses

 

In May 2020, the Company received $0.9 million in net proceeds from the sale of its New Jersey Net Operating Losses under the State of New Jersey NOL Transfer Program.